{"nct_id":"NCT02094521","title":"Evaluation of Optimal Dosing Conditions for GLP-1 Analogue NNC0113-0987 When Administered Orally in Healthy Male Subjects","status":"COMPLETED","status_verified_date":"2015-01","start_date":"2014-03","start_date_type":null,"primary_completion_date":"2014-07","primary_completion_date_type":"ACTUAL","completion_date":"2014-07","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVO"]}